Superconductor technologies inc (SCON)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-1,079

-1,928

-2,375

-2,591

-2,335

-2,262

-

-2,169

-1,522

-2,178

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,629

-

-2,874

-3,078

-2,630

-2,399

-2,373

-2,412

-1,418

-2,849

-2,412

-55

-2,935

-3,875

-3,454

-2,436

-2,408

-2,259

-2,262

-3,419

-2,988

-3,132

-3,329

-3,209

-3,713

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

38

116

235

234

235

234

-

230

228

323

411

446

460

568

403

579

577

580

526

683

522

727

333

334

335

330

330

357

355

234

109

74

64

66

171

224

199

211

Stock-based compensation expense

21

17

23

23

24

40

-

14

13

17

41

99

98

103

228

257

258

261

579

534

533

552

349

157

169

187

74

122

130

166

69

226

238

321

334

411

423

395

Provision for excess and obsolete inventories

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

88

90

92

-

-

-

-

Write-off of intangibles

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8

-79

-

-55

-87

0

0

-74

0

-770

Adjustments to fair value of warrant derivatives

-

-

-

-

-

0

-

3

16

33

32

59

11

-3

145

17

0

21

966

503

750

2,633

384

984

-656

-232

-

-

-

-

-

-

-

-

-

-

-

-

Adjustments to warrant exercise price

-

-

-

-

-

0

-

0

0

24

-

-

-

-

-

-

-

-

170

0

0

367

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain from sale of patents, property and equipment

510

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1

6

6

6

96

92

-337

0

6

48

7

22

15

-

-

-

-

Write-down of intangibles

134

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Obsolete inventory

190

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

58

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Gain) loss from investment in Resonant LLC joint venture

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-56

-182

-

-

-

-

-

-

-

-

Changes in assets and liabilities:
Equity loss from Resonant LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Accounts receivable

124

-

-

-

0

-108

-

-449

376

30

65

87

0

-9

4

-10

-54

32

4

-2

3

-50

54

-246

-30

302

-121

-105

-110

220

-657

496

103

119

-24

-23

-470

471

Inventories

-5

116

-55

104

-75

23

-

-3

-17

67

56

-16

9

-15

4

3

-102

43

2

119

0

-16

-12

19

-12

3

-16

-15

-38

94

-539

-474

-115

-161

-74

97

350

-277

Prepaid expenses and other current assets

58

-70

-67

204

-51

-66

-

-82

194

-68

-81

-48

193

-90

-14

-59

0

61

-37

-173

74

-100

211

-52

-130

-108

-28

132

105

-87

-220

-28

126

-37

144

27

76

-120

Patents and licenses

-

-

-

-

-

-15

-

0

0

1

-23

-118

-112

41

0

36

44

50

71

19

32

6

16

12

22

20

96

26

15

23

42

42

145

-30

32

-12

4

42

Other assets

-

-

-

-

-

-

-

-

-

-

0

0

0

-27

-2

0

96

-126

-1

-3

-92

-32

-4

-3

-23

-32

150

32

-2

-32

-2

-2

-3

-2

178

-23

-1

-2

Accounts payable, accrued expenses and other current liabilities

-87

-23

-41

100

-77

-148

-

141

-26

45

-145

225

-29

-183

-110

98

70

-67

-138

28

-284

-62

-61

-28

-562

426

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable, accrued expenses and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

399

-128

165

-179

-49

-62

237

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,038

-

-1,922

-2,157

-1,895

-2,267

-1,591

-2,408

-2,218

-2,883

-2,346

-2,755

-2,041

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable, accrued expenses and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

957

-214

405

Net cash used in operating activities

-1,470

-2,041

-2,193

-2,542

-2,027

-1,970

-

-1,253

-1,876

-1,832

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,218

-1,985

-1,806

-

-1,909

-3,280

-2,176

-3,546

-1,666

-2,760

-2,046

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment

-

-

-

-

-

0

-

184

0

5

-

-

-

-

-

-

-

0

0

0

95

46

184

615

1,408

1,497

609

28

3

178

760

965

897

966

214

1,393

612

35

Net proceeds from the sale of patents, property and equipment

1,212

-

-

-

0

-

-

-

-

-

-

-

-

0

-

-

-

0

0

0

0

1

0

0

0

96

91

1

0

6

48

7

22

15

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-95

-45

3,143

-615

-1,408

-1,401

-

-

-

-

-

-

-

-

-

-

-

-

Repurchase of common shares for withholding obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-15

1

5

129

0

0

25

278

Net cash provided in investing activities

1,212

-

-

-

0

0

-

-184

0

-5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-27

-3

-172

-

-958

-875

-951

55

-1,393

-612

-35

CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from sale of common, prefunded warrants and preferred stock

-

-

-

-

-

0

-

7,980

0

1,700

-

-

-

-

-

-

-

0

-

-

0

4,596

-

-

-

-

-

-

-

-

2,690

0

0

6,621

0

0

0

12,402

Net proceeds from the exercise of warrants

1,388

-

-

-

0

-

-

-

-

-

0

0

200

0

-

-

-

0

0

0

0

1,687

-

334

0

3,751

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

8,572

0

0

6,283

0

334

0

3,751

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

1,388

2,479

0

1,421

0

0

-

7,980

0

1,700

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

-5

6,492

0

0

-25

12,124

Net increase (decrease) in cash and cash equivalents

1,130

438

-2,193

-1,121

-2,027

-1,970

-

6,543

-1,876

-137

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-1,952

-2,038

-

-22

-2,157

-1,895

6,305

-1,591

-2,503

4,020

260

-2,627

-4,163

309

-2,808

8,654

-43

-1,978

1,132

-2,868

-4,160

3,365

-3,491

-3,059

-3,397

10,043

Warrant liability converted to capital in excess of par

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

669

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-